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Abstract 
BACKGROUND: Coronary artery bypass graft (CABG) surgery remains the gold standard treatment for left main 
coronary artery and multivessel disease. In the last decade, arterial conduit clearly has had superiority over venous 
conduit. The aim of this study is to report and compare both types of conduit in Erbil Cardiac Center, Iraq. 
METHODS: A retrospective cohort study was used to compare patients who received total arterial grafts (n = 25) 
with patients who had saphenous-vein bypass grafts (n = 25), at the point of gender, age, operation duration, post-
operative complications, hospital stay, and the 6-month cardiac ejection fraction (EF) improvement. 
RESULTS: All patients of arterial group were men in comparison to 68% men versus 32% women in venous group; 
mean age of the patients was 50 years and 61 years for arterial and venous conduits, respectively. Duration of 
operation was 3.97 hours and 4.27 hours, hospital stay was 5.42 days and 7.20 days, and EF improvement was 
11.48% and 4.40% for arterial and venous conduits, respectively. Although the duration of operation was not 
statistically significant, the total duration of hospital stay and EF improvement were statistically significant. 
CONCLUSION: Arterial conduit has started in the last decades. Although it technically needs more accuracy and 
time, it has a better outcome compared to the venous conduit. 
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Introduction1 
In severe coronary artery disease (CAD), 
coronary artery bypass graft (CABG) surgery 
is indicated to re-establish an adequate blood 
supply to the ischemic myocardium.1,2 CABG 
is a standard surgical procedure for advanced 
CAD. It is well known for decreasing the 
symptoms and improving survival.3-5 
It reduces morbidity and mortality in 
patients with left main stem (LMS), triple-
vessel disease (TVD), and/or proximal stenosis 
of the left anterior descending coronary artery 
(LAD) compared to medical therapy,2,6,7 and 
decreases coronary repeated revascularization 
rate in comparison to percutaneous coronary 
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intervention (PCI).2,8 Advances in medical 
therapy for ischemic heart disease (IHD) and 
heart failure (HF) have improved the outcomes 
of patients with CAD. The survival advantage 
of CABG surgery over medical therapy in 
patients with stable angina has been 
challenged.9 Effectiveness of CABG surgery is 
directly related to graft patency.2,10 
The efficacy of CABG is dependent on the 
long-term patency of the selected conduits. 
The left internal thoracic artery (LITA) is 
established as the best conduit for CABG, 
particularly for grafting the LAD.11 After 
initially unfavorable outcomes,12 there has 
been an emerging and renewed enthusiasm for 
the radial artery (RA) as an alternative conduit 
through the use of improved harvesting 
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Conduits are divided into two groups: arterial 
and venous.  
Venous conduits [saphenous vein grafts (SVGs)]  
Excellent patency can be achieved in the first 
five years with SVGs. They are unaffected by 
native coronary artery stenosis (NCAS); 
however, endothelial and media hyperplasia 
(5-8 years post-operatively) and subsequent 
atherothrombosis markedly diminish patency. 
Attention to harvesting, avoidance of trauma, 
over-distension, and preservation of vessel 
wall integrity and vasa vasorum may 
contribute to longer-term patency, as may the 
use of statins.  
Arterial conduits 
LITA: Since the publication by Tatoulis et al. in 
1986 (and other publications around that time), 
it has been universally accepted that LITA is 
the best coronary graft and LITA to LAD is the 
single most important component of any 
coronary revascularization in reducing 
recurrent cardiac events and enhancing 
survival.14 LITA-LAD improves perioperative 
mortality and is strongly recommended in all 
situations including emergency 
revascularization, older age, and in patients 
with co-morbid states [diabetes, obesity, renal 
dysfunction, and chronic obstructive airway 
disease (COAD)].15  
The right internal thoracic artery (RITA)  
The RITA is biologically identical to the 
LITA.16-20 Hence, it is not logical to universally 
proclaim the LITA as the best conduit. The 
RITA is usually of greater diameter than the 
LITA in right-handed people and potentially 
easier to use.  
RA 
The RA is often considered as the second graft 
of choice after the ITA, having a high patency 
rate close to 90% up to 10 years after CABG.21 
As known well, the LITA is the preferred 
graft in myocardial revascularization due to 
high patency in addition to early and late 
survival rates. The radial and gastroepiploic 
arteries may also be considered as alternative 
arterial grafts. SVGs are the most commonly-
used venous grafts. Arterial grafts are superior 
to venous grafts due to their long-term patency 
rates. According to the literature, 90% of ITAs 
remain patent 10 years after surgery, while 
only 50% of saphenous grafts remain patent.22 
In 1973, Carpentier et al. first performed 
surgery using an RA. Subsequently, they 
recommended that RA should not be used due 
to the 35% incidence of narrowing or stenosis 
of the conduit.12 In 1992, Acar et al.13 reported 
promising mid-term and long-term patency 
rates for RA and argued that it had gained 
widespread acceptance as a conduit for CABG 
as a result of its suitable inner diameter, good 
length, minimal donor site discomfort, ease of 
handling, and excellent early clinical results. 
Improvements in the harvesting techniques 
and postoperative administration of calcium 
channel blockers (CCBs) were also expected to 
improve the results. Today, RA as an arterial 
graft is the second preferred graft after LITA 
for CABG. In our study, we compared the 
long-term patency rates of arterial and venous 
grafts by angiography in patients with 
recurrent ischemic symptoms. 
Despite the patency rate difference between 
different types of grafts, technically they are 
different during harvesting and grafting on the 
epicardium. On the other hand, harvesting site 
may affect the patient’s condition at 
perioperative period and hospitalization  
in general. 
The superiority of the arterial conduit to the 
venous graft is well studied and mentioned in 
different literatures and still is discussed. The 
aim of this study is to evaluate the outcome of 
patients of both groups and to give patients the 
greatest possible benefit of CABG. 
Materials and Methods 
This retrospective cohort study included 
candidates for doing bypass graft surgery. 
Only cases with three graft operations were 
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groups, first those with arterial conduit LITA, 
RITA, and RA harvested from left forearm and 
second group were cases whose great 
saphenous vein (GSV) was used as a conduit. 
Data were collected carefully from each 
patient: gender, age, operation duration 
(duration of bypass and duration of cross 
clamp), post-operative complications 
(reopening and infection), day of mobilization, 
total hospital stay, and the 6-month cardiac 
ejection fraction (EF) improvement. 
Data entry and coding were performed 
using Microsoft Excel (version 2016). The data 
were transferred to and analyzed by SPSS 
software (version 20, IBM Corporation, 
Armonk, NY, USA). Descriptive statistics 
[percentage, mean, and standard deviation (SD)] 
were used. T-test was used to test statistical 
significance between two groups. The ethical 
clearance (R-C-64) was obtained from the Ethical 
Committee of Surgical Specialty Hospital, 
Hawler Medical University, Erbil, Iraq. 
Results 
The study included 50 patients, 25 patients for 
each group. From venous group 17 (68%) were 
men and 8 (32%) were women, while all 
patients from arterial group were men  
(P = 0.002) (Tables 1 and 2).  
Table 1. Association between study groups and 
gender  





 Male 17 (68.0) 25 (100) 43 (84.3) 
Female 8 (32.0) 0 (0) 8 (15.7) 
Total 25 (100) 25 (100) 51 (100) 
 
Mean and SD of age of venous group was 
60.92 ± 6.70 years and for arterial group, it was 
50.46 ± 5.03 years (P = 0.001) (Figure 1). 
Duration of operation was 4.27 hours for 
venous group and 3.97 hours for arterial 
group, which was not statistically significant 
(P = 0.040) (Figure 2). 
 
 
Figure 1. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to age 
 
Table 2. Comparison between venous and arterial conduits in regard to different variables  
Variables  Groups N Mean ± SD P 
Age (year) Venous conduit 25 60.92 ± 6.70 0.001 
Arterial conduit 25 50.46 ± 5.03 
Hospital stay Venous conduit 25 7.20 ± 1.32 0.001 
Arterial conduit 25 5.42 ± 0.75 
Duration of operation Venous conduit 25 4.27 ± 0.51 0.040 
Arterial conduit 25 3.97 ± 0.56 
Duration of cross clamp Venous conduit 25 30.92 ± 3.95 0.001 
Arterial conduit 25 45.73 ± 5.22 
Duration of bypass Venous conduit 25 62.08 ± 7.80 0.001 
Arterial conduit 25 48.31 ± 5.16 
EF Venous conduit 25 52.72 ± 7.46 0.006 
Arterial conduit 25 57.23 ± 2.61 
Mobilization day Venous conduit 25 2.44 ± 0.50 0.001 
Arterial conduit 25 1.19 ± 0.40 
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Figure 2. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to duration of operation 
 
Duration of total bypass was 62.08 minutes 
for venous and 48.31 minutes for arterial 
conduits (P = 0.001) (Figure 3), while duration 
of cross clamp was 30.92 minutes and 45.73 
minutes, respectively (P = 0.001) (Figure 4).  
 
 
Figure 3. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to duration of  
bypass (minute) 
 
Both of them were statistically significant. 
Reopening incidence was 3 cases for venous 
and 5 cases for arterial conduit (P = 0.470) 
(Table 3). Infection occurred in 5 patients of 
venous and 2 patients of arterial conduit  
(P = 0.190) (Table 4). Patients with arterial 
conduit were mobilized earlier than patients 
with venous conduit at 1.19 for arterial and 
2.44 for venous conduit with statistical 
significance (P = 0.001) (Table 5). 
 
Figure 4. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to duration of cross 
clamp (minute) 
 
Rate of improvement for EF was 4.40% for 
venous conduit (48.32% to 52.72%) (Figure 5), 
while it was 11.48% for arterial conduit 
(45.68% to 57.16%) which was statistically 
significant (P = 0.006) (Figure 6).  
 
Table 3. Association between study groups and 
reopening of the operation site 





No 22 (88.0) 21 (80.8) 43 (84.3) 
Yes 3 (12.0) 5 (19.2) 8 (15.7) 
Total 25 (100) 26 (100) 51 (100) 
P = 0.470 
 
Overall time for hospital stay was 5.42 days 
and 7.20 days for arterial and venous conduit 
groups, respectively, which was statistically 
significant (P = 0.001) (Figure 7). 
 
Table 4. Association between study groups and 
infection of site of operation  





No 20 (80.0) 24 (92.3) 44 (86.3) 
Yes 5 (20.0) 2 (7.7) 7 (13.7) 
Total 25 (100) 26 (100) 51 (100) 
P = 0.190 
Discussion 
Despite the proven benefits of ITA on long-
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accepted as the conduit of choice for 
myocardial revascularization.  
 
Table 5. Comparison between venous and 
arterial conduits in regard to mobilization day 
Variables  Groups N Mean ± SD P 
Mobilization 
day 
Arterial conduit 25 57.23 ± 2.61 0.001 
Venous conduit 25 2.44 ± 0.50 
Arterial conduit 25 1.19 ± 0.40 
SD: Standard deviation 
 
Other studies show that SVGs patency is 
still problematic at 10 years.16,18 On the other 
hand, the difference between them during 
perioperative period also plays a crucial role.  
 
 
Figure 5. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to rate of improvement 
for ejection fraction (EF) (%) 
 
Harvesting the conduit and using it for 
grafting also affect the procedure in general, 
intra, and postoperative period more precisely.  
 
 
Figure 6. Saphenous vein graft (SVG) versus 
total arterial graft in coronary artery bypass 
graft (CABG) according to venous conduit (%) 
 
Figure 7. Saphenous vein graft (SVG) versus total 
arterial graft in coronary artery bypass graft 
(CABG) according to duration of hospital stay 
 
Accuracy by well-trained hand and more 
precaution for anastomosis play an important 
role in intraoperative period. Venous harvesting 
usually needs a large wound at lower extremity 
with possibility of more infection which 
elongates the duration of hospital stay and 
delays mobilization postoperatively. 
Total arterial conduit is more preferably 
done for young and male candidates for 
coronary bypass surgery. Cross clamp and 
bypass time are two important parameters 
during operation which determine subclinical 
tissue injury. Although the cross clamp time 
was longer for arterial group, total bypass time 
was significantly shorten because there was no 
proximal anastomosis. More tissue dissection 
in venous conduit leads to more incidence of 
infection, delayed mobilization, and prolonged 
hospital stay. 
Conclusion 
Although it is more difficult technically 
regarding harvesting and grafting, arterial 
conduit has better outcome compared to 
venous conduit at perioperative period with 
improvement of cardiac contractility later. 
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